Pharma
One Medical providers will be able to request drug consultations on complex medication regimens for seniors managing chronic conditions.
The proposed class action lawsuit alleges the pharmacy benefit manager worked with rival PBMs to exert its influence in the market and fix reimbursement rates and fees.
The offering will give patients with diabetes, migraines and obesity access to care providers and home delivery of Lilly medications via third-party vendors.
The pharma giant will also pay $55 million to fund the point-of-care diagnostics platform until the acquisition closes, which is expected to occur by mid-2024.
Informa Markets will manage the massive health technology conference, while HIMSS will continue overseeing content and programming.
According to the study published in npj Digital Medicine, high scores for depressive symptoms and lower-than-excellent self-rated health were associated with less smartwatch use.
Elena Viboch, partner at General Catalyst, discusses her predictions for biotech and health tech investing and how startups can grow in a more constrained economic environment.
Drug development platform Quris raised another $9 million, and PharmStars is accepting applications for its accelerator cohort focused on women's health and health equity.
The Drug Enforcement Administration says the digital pharmacy wrongfully distributed thousands of prescription stimulants for ADHD, including Adderall.
The companies first partnered in 2020 to develop a prescription digital therapeutic for schizophrenia. They said a treatment strategy for the condition "would benefit from a multi-product approach."